14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
IPOD vs ABI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
IPOD Overall Winner
6-Pillar Tally: IPOD 3 – 0 ABI (3 Tie)
Matrix Metrics: IPOD 9 – 0 ABI
As of Nov 16, 2026, IPOD (IPOD) is the stronger overall head-to-head candidate over ABI (ABI) in the Tradestie Institutional Equity Comparison Engine, winning 9–0 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IPOD carries a Unified Composite Score of 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin), whereas ABI carries 49.0/100 (HOLD) at $24.48 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: IPOD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile ABI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPOD vs ABI. Trailing 12-month operating profitability (IPOD 0.0% vs ABI N/A) and valuation multiples (IPOD N/M vs ABI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Shell Companies value chain with $210.0M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
ABI Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ IPOD vs ABI Key Questions & Quantitative Answers
As of Nov 16, 2026, IPOD (IPOD) is the stronger overall head-to-head candidate over ABI (ABI) in the Tradestie Institutional Equity Comparison Engine, winning 9–0 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IPOD carries a Unified Composite Score of 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin), whereas ABI carries 49.0/100 (HOLD) at $24.48 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: IPOD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile ABI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
IPOD leads the Growth & Scale pillar: IPOD posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ABI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IPOD generates N/A in USD-normalized revenue versus N/A for ABI. In operating R&D and SG&A reinvestment, IPOD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABI.
IPOD screens cheaper on headline valuation multiples. IPOD trades at N/M Forward P/E, 39.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ABI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IPOD (0.0% ROE) versus ABI (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, IPOD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 2% Vol realized risk). By comparison, ABI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.